Evonik Industries (EVK) Given a €38.00 Price Target at Morgan Stanley

Share on StockTwits

Morgan Stanley set a €38.00 ($44.19) price objective on Evonik Industries (FRA:EVK) in a research note released on Friday morning. The firm currently has a buy rating on the stock.

Other equities research analysts have also recently issued reports about the stock. Deutsche Bank set a €40.00 ($46.51) price target on shares of Evonik Industries and gave the company a buy rating in a research report on Wednesday, July 18th. Warburg Research set a €38.00 ($44.19) price objective on shares of Evonik Industries and gave the company a buy rating in a research note on Wednesday, September 26th. HSBC set a €26.00 ($30.23) price objective on shares of Evonik Industries and gave the company a sell rating in a research note on Tuesday, July 3rd. Baader Bank set a €40.00 ($46.51) price objective on shares of Evonik Industries and gave the company a buy rating in a research note on Tuesday, July 17th. Finally, Credit Suisse Group set a €34.30 ($39.88) price objective on shares of Evonik Industries and gave the company a buy rating in a research note on Wednesday, July 18th. Five research analysts have rated the stock with a sell rating, five have issued a hold rating and twelve have given a buy rating to the company. Evonik Industries currently has an average rating of Hold and a consensus price target of €35.10 ($40.81).

Shares of EVK traded down €0.14 ($0.16) during trading on Friday, reaching €27.89 ($32.43). 831,074 shares of the company traded hands. Evonik Industries has a twelve month low of €26.78 ($31.14) and a twelve month high of €32.97 ($38.34).

About Evonik Industries

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.

Read More: What are the Benefits of Index Funds?

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Host Hotels and Resorts Inc  Expected to Post Quarterly Sales of $1.28 Billion
Host Hotels and Resorts Inc Expected to Post Quarterly Sales of $1.28 Billion
NEVERDIE  Hits Market Cap of $439,225.00
NEVERDIE Hits Market Cap of $439,225.00
Scorecoin  Trading 2.8% Lower  Over Last Week
Scorecoin Trading 2.8% Lower Over Last Week
Hormel Foods Corp  Expected to Announce Quarterly Sales of $2.55 Billion
Hormel Foods Corp Expected to Announce Quarterly Sales of $2.55 Billion
Focus Financial Partners Inc  Given Consensus Rating of “Hold” by Brokerages
Focus Financial Partners Inc Given Consensus Rating of “Hold” by Brokerages
MarteXcoin Trading Down 9.2% Over Last Week
MarteXcoin Trading Down 9.2% Over Last Week


Leave a Reply

© 2006-2018 Ticker Report. Google+.